Part 14 of our Bridging the Gap Series (Summary of the webinar session held in january 2025) In early January 2025, Bridging the Gap panelists George Eastwood and Patrick Hanley visited Washington, D.C., to advocate for increased support and funding for life-saving cell and gene therapies. During its first year, the Bridging the Gap Webinar Series, sponsored […]
View Blog
Scientific research is the cornerstone of innovation, but it can come at an environmental cost. In the pursuit of scientific advancement, life sciences laboratories have become significant contributors to global plastic waste, where consumables like pipette tips, gloves, and culture flasks are essential for experiments. Unfortunately, these items are primarily single-use and plastic-based, leading to […]
View Blog
Azenta Life Sciences has officially opened its state-of-the-art biorepository facility in the Greater Boston area, designed to serve the unique storage and management needs of the biotech and life sciences industries. Located strategically to support Cambridge and Boston’s vibrant community of biotech and pharmaceutical companies, the facility offers advanced sample storage and handling capabilities, helping […]
View Blog
Part 13 of our Bridging the Gap Series (Summary of the webinar session held in December 2024) Groundbreaking advancements in cell and gene therapies offer unprecedented hope for patients battling cancers, autoimmune diseases, and genetic disorders. Yet, transforming academic breakthroughs into therapies ready for patients is a complex and challenging journey. Issues such as scalable manufacturing processes, […]
View Blog
Part 1 of our Cryo Cold Chain Management for CGT Series With a projected rate of 10-20 product approvals per year, the global cell and gene therapy (CGT) industry is rapidly evolving. The clinical pipeline delivers a promise to the patient population with unmet medical needs ranging from oncology to autoimmune diseases and rare genetic conditions. In […]
View Blog
Part 12 of our Bridging the Gap Series (Summary of the webinar session held in November 2024) Pictured in photo: Sickle cell warrior Jimi Olaghere climbed Mt. Kilimanjaro after receiving advanced gene therapy. The incredible potential of gene therapies like chimeric antigen receptor T-cell therapy (CAR-T) and clustered regularly interspaced short palindromic repeats (CRISPR) to cure genetic diseases […]
View Blog
Recap of 1 Year of our Bridging the Gap Series In November 2024, Azenta Life Sciences celebrated the one-year anniversary of its “Bridging the Gap” webinar series, an insightful resource in cell and gene therapy (CGT) education, co-sponsored by the Emily Whitehead Foundation. Over the past year, this series has become a resource for industry experts and […]
View Blog
What is ISO 9001:2015? ISO 9001:2015 is an internationally recognized standard that defines the criteria for ongoing enhancement of a QMS. It emphasizes the importance of consistent performance, efficiency, and customer satisfaction. Organizations that adhere to this standard are better equipped to streamline processes, enhance their product and service quality, and ultimately provide a superior […]
View Blog
Part 11 of our Bridging the Gap Series (Summary of the webinar session held in October 2024) In the rapidly advancing world of cell and gene therapy, we are witnessing groundbreaking innovations that have the potential to cure once-incurable diseases like cancer and sickle cell. Yet, as these transformative therapies emerge, a troubling reality persists: access to […]
View Blog